2014 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Biotronik Begins the Global BIOLUX P-III All-Comers Registry

October 30, 2014—Biotronik announced the initiation of the BIOLUX P-III All-Comers Registry with the first patient implantation in the study, which will collect and asse…

Medtronic and Covidien Confirm Plan to Close Acquisition by Early 2015

October 29, 2014—In a statement to the US Securities and Exchange Commission, Medtronic, Inc. and Covidien confirmed that the companies expect the closing of Medtronic&r…

TriVascular Begins LIFE Postmarket Registry for Ovation Prime in Fast-Track Setting

October 27, 2014—TriVascular Technologies, Inc. announced the commencement of enrollment in the LIFE Study, a multicenter postmarket registry designed to evaluate the Ov…

Essential Medical’s X-Seal Vascular Closure Device Approved in Europe

October 27, 2014—Essential Medical, Inc. announced that it has received European CE Mark approval for its X-Seal vascular closure device. X-Seal closes femoral…

FDA Clears ReFlow Medical’s Wingman35 Crossing Catheter

October 23, 2014—ReFlow Medical, Inc. announced US Food and Drug Administration (FDA) marketing clearance of the company’s Wingman35 crossing catheter. The Wingman…

FDA Approves Pivotal SONATA Study for Gynesonics VizAblate System to Treat Uterine Fibroids

October 22, 2014—Gynesonics, Inc. announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption for the pivotal SONATA trial …

Dr. Thomas J. Fogarty Awarded Presidential National Medal of Technology and Innovation

October 22, 2014—The Fogarty Institute for Innovation announced that Thomas J. Fogarty, MD, has been awarded the Presidential National Medal of Technology and Innovation…

Click here for more News coverage

Current Supplement

Sponsored by CORDIS CORPORATION

New Standards in Angioplasty

Expert discussion and challenging case reviews show that we may be on the verge of a major transformation in angioplasty-centric therapy for lower extremity interventions.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

Embolization

advertisement

 

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media